The 16-week-old patient, Megha, was originally evaluated in India for symptoms concerning glaucoma in need of surgical intervention. Her father, David, and paternal uncle are MH susceptible, based on muscle biopsy testing. There were multiple centers in India capable of managing childhood glaucoma, but access to the MH antidote drug dantrolene is limited throughout much of India. In addition, Megha’s father wanted her treated in the U.S. to maximize her safety.
Ophthalmologic surgeon Dr. James Brandt from the UC Davis Eye Center was contacted by an Aarogya Seva-Global Health Volunteer Alliance volunteer about transferring Megha to UC Davis Health for her glaucoma surgery. Dr. Brandt consulted Dr. Niroop Ravula, pediatric anesthesiologist in the UC Davis Health Pediatric Anesthesia division, and Dr. Tim Tautz, director of the UC Davis MH Biopsy Testing Center, about managing this patient at UC Davis Health. With the help of Aarogya Seva-Global Health Volunteer Alliance and online fundraising, Megha traveled to the U.S. with her family for surgery.
Since arriving at UC Davis Health, Megha has successfully undergone two eye procedures under non-triggering general anesthesia after proper anesthesia workstation preparation without any complications. After the follow-up visit at UC Davis Ophthalmology, Dr. Brandt expects Megha to have normal vision.
Megha’s story demonstrates that adequate preparation and a team-centered approach are vital to ensure patient safety during perioperative course and led to a successful outcome.
UC Davis Medical Center is one of six designated MH testing sites in the U.S. and is also involved in collecting data for the North American MH Registry. We utilize laboratories at UC Davis to perform muscle biopsies and other tests. The director of the testing center, Dr. Tautz, serves as a consultant to the MH Hotline and is available to answer questions and concerns about MH from physicians and other healthcare personnel.